Serine/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription

被引:0
|
作者
Scott, Haley M. [1 ]
Smith, Mackenzie H. [1 ]
Coleman, Aja K. [1 ]
Armijo, Kaitlyn S. [1 ]
Chapman, Morgan J. [1 ]
Apostalo, Summer L. [1 ]
Wagner, Allison R. [1 ]
Watson, Robert O. [1 ]
Patrick, Kristin L. [1 ]
机构
[1] Texas A&M Hlth, Coll Med, Dept Microbial Pathogenesis & Immunol, Bryan, TX 77807 USA
来源
CELL REPORTS | 2024年 / 43卷 / 03期
关键词
Murine macrophages; genes; Here; Scott et al. implicate serine; genomic locus; SRSF7; promotes; RNA-POLYMERASE-II; NF-KAPPA-B; SR PROTEINS; REGULATORS; TARGET; PHOSPHORYLATION; ACTIVATION; EXPRESSION; ADAPTERS; RELEASE;
D O I
10.1016/j.celrep.2024.113816
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tight regulation of macrophage immune gene expression is required to fight infection without risking harmful inflammation. The contribution of RNA -binding proteins (RBPs) to shaping the macrophage response to pathogens remains poorly understood. Transcriptomic analysis reveals that a member of the serine/arginine-rich (SR) family of mRNA processing factors, SRSF7, is required for optimal expression of a cohort of interferon -stimulated genes in macrophages. Using genetic and biochemical assays, we discover that in addition to its canonical role in regulating alternative splicing, SRSF7 drives transcription of interferon regulatory transcription factor 7 (IRF7) to promote antiviral immunity. At the Irf7 promoter, SRSF7 maximizes STAT1 transcription factor binding and RNA polymerase II elongation via cooperation with the H4K20me1 histone methyltransferase KMT5a (SET8). These studies define a role for an SR protein in activating transcription and reveal an RBP-chromatin network that orchestrates macrophage antiviral gene expression.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Interferon Regulatory Factor 7 (IRF7): The Possible Link Between Inflammation and Fibrosis in SSc Pathogenesis
    Wu, Minghua
    Salazar, Gloria
    Zhou, Xiaodong
    Guo, Xinjian
    Reveille, John D.
    Agarwal, Sandeep K.
    Blackburn, Michael R.
    Mayes, Maureen D.
    Assassi, Shervin
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [22] IRF3 and IRF7 are key Elements of the Type I IFN Response in Patients with Hepatitis B
    Schwarz, David
    Churin, Yuri
    Mollenkopf, Hans-Joachim
    Roderfeld, Martin
    Roeb, Elke
    INTERNIST, 2018, 59 : S38 - S38
  • [23] Deletion of Serine/Arginine-Rich Splicing Factor 3 in Hepatocytes Predisposes to Hepatocellular Carcinoma in Mice
    Sen, Supriya
    Langiewicz, Magda
    Jumaa, Hassan
    Webster, Nicholas J. G.
    HEPATOLOGY, 2015, 61 (01) : 171 - 183
  • [24] Phosphorylation of serine/arginine-rich splicing factor 1 at tyrosine 19 promotes cell proliferation in pediatric acute lymphoblastic leukemia
    Xu, Liting
    Zhang, Han
    Mei, Mei
    Du, Chaohao
    Huang, Xiahe
    Li, Jing
    Wang, Yingchun
    Bao, Shilai
    Zheng, Huyong
    CANCER SCIENCE, 2018, 109 (12): : 3805 - 3815
  • [25] The Ubiquitin E3 Ligase RAUL Negatively Regulates Type I Interferon through Ubiquitination of the Transcription Factors IRF7 and IRF3
    Yu, Yanxing
    Hayward, Gary S.
    IMMUNITY, 2010, 33 (06) : 863 - 877
  • [26] Fibroblast Specific Interferon Regulatory Factor 7 (IRF7) Expression Is a Key Link Between Type I Interferon Activation and the Exaggerated Dermal and Pulmonary Fibrosis in Systemic Sclerosis
    Wu, Minghua
    Alonso, Jerry
    Charles, Julio
    Skaug, Brian
    Mills, Tingting
    Mayes, Maureen
    Assassi, Shervin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3304 - 3306
  • [27] Intracellular trafficking, IRF7 and type-I-IFN responses
    Elaine Bell
    Nature Reviews Immunology, 2005, 5 : 361 - 361
  • [28] SGIV VP82 inhibits the interferon response by degradation of IRF3 and IRF7
    Wang, Yu
    Liu, Shanxing
    Wang, Wenji
    Liu, Lin
    Zhao, Yin
    Qin, Qiwei
    Huang, Xiaohong
    Huang, Youhua
    FISH & SHELLFISH IMMUNOLOGY, 2024, 150
  • [29] Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2
    DeLigio, James T.
    Stevens, Shaun C.
    Nazario-Munoz, Gina S.
    MacKnight, H. Patrick
    Doe, Keli K.
    Chalfant, Charles E.
    Park, Margaret A.
    MOLECULAR CANCER RESEARCH, 2019, 17 (09) : 1920 - 1930
  • [30] Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer
    Qiang Lan
    Sanam Peyvandi
    Nathalie Duffey
    Yu-Ting Huang
    David Barras
    Werner Held
    François Richard
    Mauro Delorenzi
    Christos Sotiriou
    Christine Desmedt
    Girieca Lorusso
    Curzio Rüegg
    Oncogene, 2019, 38 : 2814 - 2829